Circumventing Antivector Immunity by Using Adenovirus-Infected Blood Cells for Repeated Application of Adenovirus-Vectored Vaccines: Proof of Concept in Rhesus Macaques
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circumventing Antivector Immunity by Using Adenovirus-Infected Blood Cells for Repeated Application of Adenovirus-Vectored Vaccines: Proof of Concept in Rhesus Macaques
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 86, Issue 20, Pages 11031-11042
Publisher
American Society for Microbiology
Online
2012-08-02
DOI
10.1128/jvi.00783-12
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?
- (2012) Thanh-Nhan Nguyen-Pham et al. Clinical & Developmental Immunology
- Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China
- (2011) Caijun Sun et al. VACCINE
- Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys
- (2010) Caijun Sun et al. JOURNAL OF INFECTION
- Immune responses that correlate with HIV-1 protection?
- (2009) Christiane Moog AIDS
- Vaccine-Induced, Simian Immunodeficiency Virus-Specific CD8+ T Cells Reduce Virus Replication but Do Not Protect from Simian Immunodeficiency Virus Disease Progression
- (2009) J. C. Engram et al. JOURNAL OF IMMUNOLOGY
- Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
- (2009) Kara L O'Brien et al. NATURE MEDICINE
- Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells
- (2009) Natalie A Hutnick et al. NATURE MEDICINE
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1
- (2009) A. Benlahrech et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Shielding Adenoviral Vectors with Polyethylene Glycol on Vector-Specific and Vaccine-Mediated Immune Responses
- (2008) Eric A. Weaver et al. HUMAN GENE THERAPY
- Activation of a dendritic cell–T cell axis by Ad5 immune complexes creates an improved environment for replication of HIV in T cells
- (2008) Matthieu Perreau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inactivated Simian Immunodeficiency Virus-Pulsed Autologous Fresh Blood Cells as an Immunotherapy Strategy
- (2008) R. D. Mason et al. JOURNAL OF VIROLOGY
- Comprehensive Immunological Evaluation Reveals Surprisingly Few Differences between Elite Controller and Progressor Mamu-B*17-Positive Simian Immunodeficiency Virus-Infected Rhesus Macaques
- (2008) N. J. Maness et al. JOURNAL OF VIROLOGY
- Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
- (2008) Jinyan Liu et al. NATURE
- Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans
- (2008) David I Watkins et al. NATURE MEDICINE
- Delivery of immunotherapy with peptide-pulsed blood in macaques
- (2008) Robert De Rose et al. VIROLOGY
- Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge
- (2008) Willy M.J.M. Bogers et al. VIROLOGY
- The Use of Nonhuman Primate Models in HIV Vaccine Development
- (2008) Cecilia Morgan et al. PLOS MEDICINE
- Control of Viremia and Prevention of AIDS following Immunotherapy of SIV-Infected Macaques with Peptide-Pulsed Blood
- (2008) Robert De Rose et al. PLoS Pathogens
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started